Abstract
Background: Diabetic retinopathy (DR) is a prevalent microvascular complication and it is characterized by increased vascular permeability, ischemia and neovascularization. Angiogenesis is modulated by growth factors such as vascular endothelial growth factor and angiopoietin-2. Recently, it is found that erythropoietin, besides neuroprotection, has angiogenic effects and its level is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. However, the role of erythropoietin in physiological angiogenesis of the retina and its cooperation with angiopoietin 2 remains unclear.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
